Thrombophilia Testing: from Genetic Predisposition to Discrimination

Andreas Verstraete; Kathleen Freson; Peter Verhamme; Thomas Vanassche

doi:10.1055/a-2284-4285

TH Open, Table of Contents

CC BY 4.0 · TH Open 2024; 08(02): e177-e180
DOI: 10.1055/a-2284-4285

Letter to the Editor

Thrombophilia Testing: from Genetic Predisposition to Discrimination

Andreas Verstraete

¹Department of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium

²Department of Cardiovascular Sciences, Center for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium

,

Kathleen Freson

²Department of Cardiovascular Sciences, Center for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium

,

Peter Verhamme

¹Department of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium

²Department of Cardiovascular Sciences, Center for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium

,

Thomas Vanassche

¹Department of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium

²Department of Cardiovascular Sciences, Center for Molecular and Vascular Biology, KU Leuven, Leuven, Belgium

› Author Affiliations

Abstract

Full Text

References

References
1 Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrøm J. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 2007; 5 (04) 692-699
2 Huang W, Goldberg RJ, Anderson FA, Kiefe CI, Spencer FA. Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985-2009). Am J Med 2014; 127 (09) 829-39.e5
3 Khider L, Gendron N, Mauge L. Inherited thrombophilia in the era of direct oral anticoagulants. Int J Mol Sci 2022; 23 (03) 1821
4 Baglin T, Luddington R, Brown K, Baglin C. Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet 2003; 362 (9383) 523-526
5 Christiansen SC, Cannegieter SC, Koster T, Vandenbroucke JP, Rosendaal FR. Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA 2005; 293 (19) 2352-2361
6 Coppens M, Reijnders JH, Middeldorp S, Doggen CJM, Rosendaal FR. Testing for inherited thrombophilia does not reduce the recurrence of venous thrombosis. J Thromb Haemost 2008; 6 (09) 1474-1477
7 Pernod G, Biron-Andreani C, Morange PE. et al; French group on haemostasis and thrombosis, French Society of Vascular Medicine. Recommendations on testing for thrombophilia in venous thromboembolic disease: a French consensus guideline. J Mal Vasc 2009; 34 (03) 156-203
8 Stevens SM, Woller SC, Bauer KA. et al. Guidance for the evaluation and treatment of hereditary and acquired thrombophilia. J Thromb Thrombolysis 2016; 41 (01) 154-164
9 Arachchillage DJ, Mackillop L, Chandratheva A, Motawani J, MacCallum P, Laffan M. Thrombophilia testing: a British Society for Haematology guideline. Br J Haematol 2022; 198 (03) 443-458
10 Middeldorp S, Nieuwlaat R, Baumann Kreuziger L. et al. American Society of Hematology 2023 guidelines for management of venous thromboembolism: thrombophilia testing. Blood Adv 2023; 7 (22) 7101-7138
11 Vrotniakaite-Bajerciene K, Tritschler T, Jalowiec KA. et al. Adherence to thrombophilia testing guidelines and its influence on anticoagulation therapy: a single-center cross-sectional study. Thromb Res 2023; 223: 87-94
12 Belgisch Staatsblad. Ministerieel Besluit van 28/12/2001 tot uitvoering van sommige bepalingen van het koninklijk besluit van 30 maart 2001 tot regeling van de rechtspositie van het personeel van de politiediensten. Accessible via https://etaamb.openjustice.be/nl/ministerieel-besluit-van-28-december-2001_n2001001332.html
13 Bertina RM, Koeleman BP, Koster T. et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369 (6475) 64-67
14 Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332 (14) 912-917
15 Lee DH, Henderson PA, Blajchman MA. Prevalence of factor V Leiden in a Canadian blood donor population. CMAJ 1996; 155 (03) 285-289
16 Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995; 346 (8983) 1133-1134
17 Simone B, De Stefano V, Leoncini E. et al. Risk of venous thromboembolism associated with single and combined effects of factor V Leiden, prothrombin 20210A and methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol 2013; 28 (08) 621-647
18 Middeldorp S, Henkens CMA, Koopman MMW. et al. The incidence of venous thromboembolism in family members of patients with factor V Leiden mutation and venous thrombosis. Ann Intern Med 1998; 128 (01) 15-20
19 Middeldorp S, Meinardi JR, Koopman MMW. et al. A prospective study of asymptomatic carriers of the factor V Leiden mutation to determine the incidence of venous thromboembolism. Ann Intern Med 2001; 135 (05) 322-327
20 Simioni P, Tormene D, Prandoni P. et al. Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study. Blood 2002; 99 (06) 1938-1942
21 Heit JA, Sobell JL, Li H, Sommer SS. The incidence of venous thromboembolism among Factor V Leiden carriers: a community-based cohort study. J Thromb Haemost 2005; 3 (02) 305-311
22 Bank I, Scavenius MPRB, Büller HR, Middeldorp S. Social aspects of genetic testing for factor V Leiden mutation in healthy individuals and their importance for daily practice. Thromb Res 2004; 113 (01) 7-12
23 Van Laer C, Jacquemin M, Baert S. et al. Clinical application of multigene panel testing for bleeding, thrombotic, and platelet disorders: a 3-year Belgian experience. J Thromb Haemost 2023; 21 (04) 887-895
24 Downes K, Borry P, Ericson K. et al; Subcommittee on Genomics in Thrombosis, Hemostasis. Clinical management, ethics and informed consent related to multi-gene panel-based high throughput sequencing testing for platelet disorders: communication from the SSC of the ISTH. J Thromb Haemost 2020; 18 (10) 2751-2758